Veto on vedolizumab (MLN0002) for Crohn's disease
- PMID: 19685452
- DOI: 10.1002/ibd.21078
Veto on vedolizumab (MLN0002) for Crohn's disease
Comment in
-
Response to Baumgart review.Inflamm Bowel Dis. 2010 Sep;16(9):1449. doi: 10.1002/ibd.21201. Inflamm Bowel Dis. 2010. PMID: 20128003 No abstract available.
Comment on
-
Treatment of active Crohn's disease with MLN0002, a humanized antibody to the alpha4beta7 integrin.Clin Gastroenterol Hepatol. 2008 Dec;6(12):1370-7. doi: 10.1016/j.cgh.2008.06.007. Epub 2008 Oct 1. Clin Gastroenterol Hepatol. 2008. PMID: 18829392 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources